These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27655263)

  • 1. Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol.
    Ahmed K; Kyte D; Keeley T; Efficace F; Armes J; Brown JM; Calman L; Copland C; Gavin A; Glaser A; Greenfield DM; Lanceley A; Taylor R; Velikova G; Brundage M; Mercieca-Bebber R; King MT; Calvert M
    BMJ Open; 2016 Sep; 6(9):e012863. PubMed ID: 27655263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol.
    Retzer A; Keeley T; Ahmed K; Armes J; Brown JM; Calman L; Copland C; Efficace F; Gavin A; Glaser A; Greenfield DM; Lanceley A; Taylor RM; Velikova G; Brundage M; Mercieca-Bebber R; King MT; Calvert M; Kyte D
    BMJ Open; 2018 Feb; 8(2):e017282. PubMed ID: 29431123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.
    Kyte D; Duffy H; Fletcher B; Gheorghe A; Mercieca-Bebber R; King M; Draper H; Ives J; Brundage M; Blazeby J; Calvert M
    PLoS One; 2014; 9(10):e110229. PubMed ID: 25333349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation.
    Lidington E; Hogan H; Gandolfi A; Lawrence J; Younger E; Cho H; Peckitt C; Mohammed K; Matharu S; Scerri L; Husson O; Cruickshank S; Turner R; Wedlake L
    J Patient Rep Outcomes; 2022 Dec; 6(1):128. PubMed ID: 36547735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
    Calvert M; Kyte D; Mercieca-Bebber R; Slade A; Chan AW; King MT; ; Hunn A; Bottomley A; Regnault A; Chan AW; Ells C; O'Connor D; Revicki D; Patrick D; Altman D; Basch E; Velikova G; Price G; Draper H; Blazeby J; Scott J; Coast J; Norquist J; Brown J; Haywood K; Johnson LL; Campbell L; Frank L; von Hildebrand M; Brundage M; Palmer M; Kluetz P; Stephens R; Golub RM; Mitchell S; Groves T
    JAMA; 2018 Feb; 319(5):483-494. PubMed ID: 29411037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes (PROs) in randomised controlled trials in diabetes and pregnancy: protocol for a systematic review.
    Newman C; Kgosidialwa O; Dervan L; Bogdanet D; Egan AM; Biesty L; Devane D; O'Shea PM; Dunne F
    BMJ Open; 2021 Nov; 11(11):e052506. PubMed ID: 34728453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials.
    Kyte D; Retzer A; Ahmed K; Keeley T; Armes J; Brown JM; Calman L; Gavin A; Glaser AW; Greenfield DM; Lanceley A; Taylor RM; Velikova G; Brundage M; Efficace F; Mercieca-Bebber R; King MT; Turner G; Calvert M
    J Natl Cancer Inst; 2019 Nov; 111(11):1170-1178. PubMed ID: 30959516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: implications for generalisability and clinical practice.
    Mercieca-Bebber R; Friedlander M; Calvert M; Stockler M; Kyte D; Kok PS; King MT
    J Patient Rep Outcomes; 2017; 1(1):5. PubMed ID: 29757300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol.
    Espinasse A; Solovyeva O; Dimairo M; Weir C; Jaki T; Mander A; Kightley A; Evans J; Lee S; Bedding A; Hopewell S; Rantell K; Liu R; Chan AW; De Bono J; Yap C
    BMJ Open; 2023 Mar; 13(3):e068173. PubMed ID: 36990492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects.
    Gryaznov D; Odutayo A; von Niederhäusern B; Speich B; Kasenda B; Ojeda-Ruiz E; Blümle A; Schandelmaier S; Mertz D; Tomonaga Y; Amstutz A; Pauli-Magnus C; Gloy V; Bischoff K; Wollmann K; Rehner L; Lohner S; Meerpohl JJ; Nordmann A; Klatte K; Ghosh N; Heravi AT; Wong J; Chow N; Hong PJ; Cord KM; Sricharoenchai S; Busse JW; Agarwal A; Saccilotto R; Schwenkglenks M; Moffa G; Hemkens LG; Hopewell S; von Elm E; Briel M
    Trials; 2020 Oct; 21(1):896. PubMed ID: 33115541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and Reporting of Patient-Reported Outcomes in Trials of Palliative Radiotherapy: A Systematic Review.
    Fabian A; Domschikowski J; Letsch A; Schmalz C; Freitag-Wolf S; Dunst J; Krug D
    JAMA Netw Open; 2022 Sep; 5(9):e2231930. PubMed ID: 36136335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: A systematic review of completeness of reporting and impact on interpretation.
    Mercieca-Bebber RL; Perreca A; King M; Macann A; Whale K; Soldati S; Jacobs M; Efficace F
    Eur J Cancer; 2016 Mar; 56():144-161. PubMed ID: 26851406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
    Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
    Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Reported Outcomes in Phase 3 Clinical Trials for Blood Cancers: A Systematic Review.
    Patel K; Ivanov A; Jocelyn T; Hantel A; Garcia JS; Abel GA
    JAMA Netw Open; 2024 Jun; 7(6):e2414425. PubMed ID: 38829615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported outcomes (PRO) in ovarian cancer clinical trials-lost opportunities and lessons learned.
    Friedlander M; Mercieca-Bebber RL; King MT
    Ann Oncol; 2016 Apr; 27 Suppl 1():i66-i71. PubMed ID: 27141076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A methodological survey on reporting of pilot and feasibility trials for physiotherapy interventions: a study protocol.
    Scola LFC; Moseley AM; Thabane L; Almeida M; Costa LDCM
    BMJ Open; 2019 May; 9(5):e020580. PubMed ID: 31122962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical methods and data visualisation of patient-reported outcomes in early phase dose-finding oncology trials: a methodological review.
    Alger E; Minchom A; Lee Aiyegbusi O; Schipper M; Yap C
    EClinicalMedicine; 2023 Oct; 64():102228. PubMed ID: 37781154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPIRIT 2013 Statement: defining standard protocol items for clinical trials.
    Chan AW; Tetzlaff JM; Altman DG; Laupacis A; Gøtzsche PC; Krle A-Jerić K; Hrobjartsson A; Mann H; Dickersin K; Berlin JA; Dore CJ; Parulekar WR; Summerskill WS; Groves T; Schulz KF; Sox HC; Rockhold FW; Rennie D; Moher D
    Rev Panam Salud Publica; 2015 Dec; 38(6):506-14. PubMed ID: 27440100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.